Search Results for: Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit

ERS Leadership Elections 2025: meet the candidates for Advocacy Council Chair

May 7th, 2025

Woolcock Institute of Medical Research Ltd

October 22nd, 2020

54th Annual Professional and Scientific Meeting of the Croatian Pulmonology Society HLZ

May 2nd, 2024

November 3-6, 2024.Hotel Jure / Amadria park-Solaris ŠIBENIKMAIN THEMES- Bronchiectasis- Disorders of sleep disorders- Dijagnostika tumora pluća- COPD– Case studies from clinical practice- Free topics – posters…

ERS Congress 2020: Experience real-time procedures at the Live from the Clinic sessions

August 4th, 2020

We must do more to prevent and treat pneumonia, says international respiratory group

November 8th, 2018

ERS, ELF and Lungs Europe response to the EU environmental law – 2025 implementation review

July 23rd, 2024

The changing face of lung cancer treatment

June 27th, 2016

The dynamics of respiratory science: towards 4D research

June 27th, 2016

Apply now for an ERS Fellowship in Industry

March 2nd, 2017

Join us for the Breathe online journal club

February 14th, 2017

ERS experts join call for rapid action on clean air in Europe

February 2nd, 2024

ERS event: Respiratory health in women – do we need a special focus on the female respiratory system?

February 24th, 2022

The ERJ issues a call for papers on the subject of ageing and lung health

March 26th, 2024

New Vice President and Assembly Heads announced alongside amendments to ERS Constitution and By-Laws

September 21st, 2023

Lower or higher oxygenation targets for acute hypoxemic respiratory failure

April 23rd, 2021

29th National Congress of Pulmonology

July 28th, 2025

The 29th STMRA National Congress will be held in Tunis from November 27–30, 2025. This major event gathers experts in respiratory and allergic diseases to explore topics such as infections,…

Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials

November 10th, 2019

Primary care at the ERS Congress

August 20th, 2018